Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer

Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups

(2020) Wanzun Lin et al.   Frontiers in Oncology

Integrative Analysis of Hypoxia-Associated Signature in Pan-Cancer

(2020) Qian Zhang et al.   iScience

Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data

(2019) Eunyoung Kim et al.   BMC CANCER

The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy

(2019) Najah Albadari et al.   Expert Opinion on Drug Discovery

Role of hypoxia in cancer therapy by regulating the tumor microenvironment

(2019) Xinming Jing et al.   Molecular Cancer

A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma

(2019) Stefan Salcher et al.   ONCOGENE

Role of immunotherapy in bladder cancer: past, present and future

(2018) Sabeeh-ur-Rehman Butt et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Advances in Hypoxia-Inducible Factor Biology

(2018) Hani Choudhry et al.   Cell Metabolism

Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver Metastasis

(2018) Pengcheng Bu et al.   Cell Metabolism

Hypoxia and acidosis: immune suppressors and therapeutic targets

(2018) Sultan Damgaci et al.   IMMUNOLOGY

Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesis

(2018) Huichun Liang et al.   ONCOGENE

The hypoxic tumour microenvironment

(2018) Varvara Petrova et al.   Oncogenesis

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1α

(2018) Mengxin Lu et al.   Cell Death & Disease

Hypoxia-induced PD-L1/PD-1 crosstalk impairs T-cell function in sleep apnoea

(2017) Carolina Cubillos-Zapata et al.   EUROPEAN RESPIRATORY JOURNAL

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

(2017) Sebastien Antoni et al.   EUROPEAN UROLOGY

Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1

(2017) Mei Xue et al.   Molecular Cancer

Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas

(2017) Young Jun Chai et al.   SURGERY

Hypoxic Stress-Induced Tumor and Immune Plasticity, Suppression, and Impact on Tumor Heterogeneity

(2017) Stéphane Terry et al.   Frontiers in Immunology

Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma

(2016) Hisashi Hara et al.   BRITISH JOURNAL OF CANCER

Bladder cancer

(2016) Ashish M Kamat et al.   LANCET

Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses

(2015) Ping-Chih Ho et al.   CELL

Immune Response Regulation in the Tumor Microenvironment by Hypoxia

(2015) Sara Labiano et al.   SEMINARS IN ONCOLOGY

PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation

(2014) Muhammad Zaeem Noman et al.   JOURNAL OF EXPERIMENTAL MEDICINE

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype

(2014) S. Rebouissou et al.   Science Translational Medicine

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

(2011) Andrea Facciabene et al.   NATURE

Hypoxia-driven immunosuppression: A new reason to use thermal therapy in the treatment of cancer?

(2010) Chen-Ting Lee et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis

(2009) Adrian M. Jubb et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE